NCT06533657 2026-03-12
UTOPIA-1
ZYUS Life Sciences Inc.
Phase 2 Active not recruiting
Clinical Trials
8 trialsNCT05265052 2026-03-11
3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain
3D Medicines
Phase 2 Not yet recruiting
NCT05067257 2024-03-18
Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer
Sorrento Therapeutics, Inc.
Phase 2 Suspended
NCT04042545 2021-09-16
PLENITUDE
Tetra Bio-Pharma
Phase 2 Unknown
NCT00830180 2021-04-05
Open Label Extension In Cancer Patients
Pfizer
Phase 2 Completed
NCT00101998 2017-08-30
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2 Completed
NCT00929188 2016-01-22
A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
Janssen Research & Development, LLC
Phase 2 Completed
NCT00216658 2011-01-24
Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -
Janssen Pharmaceutical K.K.
Phase 2 Completed